Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost
- PMID: 33559475
- PMCID: PMC7955350
- DOI: 10.1161/JAHA.120.019889
Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost
Keywords: Editorials; aspirin; bleeding; coronary artery disease; myocardial infarction; thrombosis; ticagrelor.
Conflict of interest statement
Dr Mehran reports grants from Abbott Laboratories, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, and OrbusNeich; personal fees from Abbott Laboratories, Boston Scientific, Medscape/WebMD, Siemens Medical Solutions, PLx Opco Inc/dba PLx Pharma Inc, Roivant Sciences, Sanofi, Medtelligence (Janssen Scientific Affairs), and Janssen Scientific Affairs; other from Abbott Laboratories, Abiomed, Bristol Myers Squibb, Claret Medical, Elixir Medical, The Medicines Company, Spectranetics/Philips/Volcano Corp, and Watermark Research Partners; and nonfinancial support and other from Regeneron Pharmaceuticals and Idorsia Pharmaceuticals Ltd. Dr Dangas reports consulting fees or honoraria from AstraZeneca, Biosensors, Boston Scientific, and Medtronic; reports research grants to the institution from Biotronik and Abbott Laboratories; and has equity (entirely divested) with Medtronic. Dr Cao has no disclosures to report.
Comment on
-
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.J Am Heart Assoc. 2021 Feb 16;10(4):e017008. doi: 10.1161/JAHA.120.017008. Epub 2021 Feb 9. J Am Heart Assoc. 2021. PMID: 33559485 Free PMC article. Clinical Trial.
References
-
- Yeh RW, Secemsky EA, Kereiakes DJ, Normand S‐L, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, et al. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA. 2016;315:1735–1749. DOI: 10.1001/jama.2016.3775. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical